PharmiWeb.com - Global Pharma News & Resources

Biotech - Press Releases

Date Title Company
03-Jul-2025 Growing Cells, Advancing Science | Primary Cell Culture Market Poised for Expansion Through 2030 The Research Insights
03-Jul-2025 Guarding Biotech Progress | Biological Safety Testing Services Market Rises with Biologics and Cell Therapies The Research Insights
02-Jul-2025 Lynozyficâ„¢ (linvoseltamab-gcpt) Receives FDA Accelerated Approval for Treatment of Relapsed or Refractory Multiple Myeloma Regeneron
02-Jul-2025 Ebenbuild Secures Euro 2.3 Million EIC Grant to Scale Digital Twin Platform for Respiratory Health Ebenbuild
02-Jul-2025 Hengst Filtration has successfully completed the acquisition of the British medical filtration specialist Hengst SE
01-Jul-2025 Sobi to amend existing agreement with Apellis for ex-U.S. royalties of Aspaveli® (systemic pegcetacoplan) Sobi
01-Jul-2025 Carthera receives EMA expert panel endorsement for Orphan Medical Device status of SonoCloud system Andrew Lloyd Associates
01-Jul-2025 Iksuda Therapeutics receives FDA IND clearance for IKS014 Iksuda Therapeutics
01-Jul-2025 PharmaForceIQ Announces Substantial Growth as it Expands Optichannel Engagement Solutions PharmaForceIQ
01-Jul-2025 Veranova Appoints Dr. Matteo Villain as Vice President of Peptides and Oligonucleotides Veranova
01-Jul-2025 Dark Genome Therapeutics Market Size to Reach USD 11,945.7 Million in 2032 Navistrat Analytics
30-Jun-2025 TRANSPLANT HOPE: NEW TECH TO ASSESS VIABILITY OF DONOR KIDNEYS Accunea
30-Jun-2025 Laverock Therapeutics expands seed funding and announces key milestone progress Laverock Therapeutics
30-Jun-2025 Novadip and Cliniques universitaires Saint-Luc report positive results for compassionate use of NVD003 on four pediatric patients Andrew Lloyd Associates
30-Jun-2025 Endo Tools Therapeutics and Fujifilm Middle East FZE partner to extend access to innovative treatments for obesity Andrew Lloyd Associates
30-Jun-2025 CD Genomics Launches Cutting-Edge EM-seq Service to Enhance Genetic Sequencing Efficiency CD Genomics
26-Jun-2025 Silo Pharma Enters Letter of Intent for JV with Hoth Therapeutics to Develop Obesity Treatment Targeting $16 Billion Global Market Silo Pharma Inc.
26-Jun-2025 Vor Bio Enters into Exclusive Global License Agreement with RemeGen for Late-Stage Autoimmune Asset PureTech
26-Jun-2025 New government genetic screening plan welcome but leaves unanswered questions, says leading biotech SynaptixBio
26-Jun-2025 CSL Behring Receives Positive IQWiG Assessment for Garadacimab in Germany CSL Behring